CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$28,982
+55.2%
15,666
-6.9%
0.00%
Q4 2022$18,672
-52.1%
16,822
+1.1%
0.00%
Q3 2022$39,000
-29.1%
16,632
-7.7%
0.00%
Q2 2022$55,000
-42.7%
18,019
+27.8%
0.00%
Q1 2022$96,000
-35.6%
14,095
-20.8%
0.00%
Q4 2021$149,000
+12.9%
17,7960.0%0.00%
Q3 2021$132,000
-57.3%
17,796
-60.9%
0.00%
Q2 2021$309,000
+15.3%
45,491
+74.0%
0.00%
Q1 2021$268,000
+46.4%
26,1390.0%0.00%
Q4 2020$183,000
-14.1%
26,1390.0%0.00%
Q3 2020$213,000
+25.3%
26,139
+6.3%
0.00%
Q2 2020$170,000
+45.3%
24,5910.0%0.00%
Q1 2020$117,000
-45.6%
24,591
+0.1%
0.00%
Q4 2019$215,000
+165.4%
24,577
+0.6%
0.00%
Q3 2019$81,000
-33.1%
24,4250.0%0.00%
Q2 2019$121,000
-19.9%
24,4250.0%0.00%
Q1 2019$151,000
+42.5%
24,425
-22.0%
0.00%
Q4 2018$106,000
-32.5%
31,319
+29.8%
0.00%
Q3 2018$157,000
-15.1%
24,1290.0%0.00%
Q2 2018$185,000
-63.0%
24,129
+7.8%
0.00%
-100.0%
Q1 2018$500,000
+70.6%
22,374
-2.7%
0.00%0.0%
Q4 2017$293,000
-19.9%
23,000
-2.1%
0.00%0.0%
Q3 2017$366,000
+120.5%
23,500
+99.2%
0.00%
Q2 2017$166,000
-40.5%
11,800
-7.1%
0.00%
-100.0%
Q1 2017$279,00012,7000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP II, LLC 1,347,829$9,152,00093.42%
Ally Bridge Group (NY) LLC 550,000$3,735,0002.77%
ACUTA CAPITAL PARTNERS, LLC 813,500$5,524,0002.58%
TRV GP III, LLC 1,148,780$7,800,0002.12%
Deep Track Capital, LP 4,259,653$28,923,0001.86%
Logos Global Management LP 1,400,000$9,506,0001.23%
PFM Health Sciences, LP 3,972,868$26,976,0001.01%
Sofinnova Investments, Inc. 1,481,219$10,057,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 248,347$1,686,0000.70%
RTW INVESTMENTS, LP 4,680,412$31,780,0000.66%
View complete list of JOUNCE THERAPEUTICS INC shareholders